BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27860123)

  • 1. Cytomegalovirus and cancer after kidney transplantation: Role of the human leukocyte antigen system?
    Wong G; Chakera A; Chapman JR; Chadban SC; Pilmore H; Craig JC; Lim WH
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27860123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantation.
    Aldridge RW; Mattes FM; Rolando N; Rolles K; Smith C; Shirling G; Atkinson C; Burroughs AK; Milne RS; Emery VC; Griffiths PD
    Transpl Infect Dis; 2015 Feb; 17(1):25-32. PubMed ID: 25572799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience.
    Selvey LA; Lim WH; Boan P; Swaminathan R; Slimings C; Harrison AE; Chakera A
    BMC Infect Dis; 2017 Jul; 17(1):501. PubMed ID: 28716027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DQ Mismatches and Rejection in Kidney Transplant Recipients.
    Lim WH; Chapman JR; Coates PT; Lewis JR; Russ GR; Watson N; Holdsworth R; Wong G
    Clin J Am Soc Nephrol; 2016 May; 11(5):875-883. PubMed ID: 27034399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIR and Human Leukocyte Antigen Genotype Associated Risk of Cytomegalovirus Disease in Renal Transplant Patients.
    Michelo CM; van der Meer A; Tijssen HJ; Zomer R; Stelma F; Hilbrands LB; Joosten I
    Transplantation; 2015 Jul; 99(7):1506-13. PubMed ID: 25427165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired direct priming of CD8 T cells by donor-derived cytomegalovirus following kidney transplantation.
    Shabir S; Kaul B; Pachnio A; Banham GD; Smith H; Chand S; Jham S; Harper L; Ball S; Rahbar A; Söderberg-Nauclér C; Moss P; Borrows R
    J Am Soc Nephrol; 2013 Oct; 24(10):1698-708. PubMed ID: 23847277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy.
    Harvala H; Stewart C; Muller K; Burns S; Marson L; MacGilchrist A; Johannessen I
    J Med Virol; 2013 May; 85(5):893-8. PubMed ID: 23508914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection in renal transplant recipients: one center's experience.
    Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
    Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors for cytomegalovirus disease in a Colombian cohort of kidney transplant recipients.
    Díaz J; Henao J; Rodelo J; García A; Arbeláez M; Jaimes F
    Transplant Proc; 2014; 46(1):160-6. PubMed ID: 24507044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Cytomegalovirus Serostatus on Allograft Loss and Mortality Within the First Year After Kidney Transplantation: An Analysis of the National Transplant Registry.
    Bruminhent J; Dajsakdipon T; Ingsathit A; Supaporn T; Prommool S; Watcharananan SP
    Transplant Proc; 2020 Apr; 52(3):829-835. PubMed ID: 32113693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus-negative kidney transplant recipients are at an increased risk for malignancy after kidney transplantation.
    Rozen-Zvi B; Lichtenberg S; Green H; Cohen O; Chagnac A; Mor E; Rahamimov R
    Clin Transplant; 2016 Sep; 30(9):980-5. PubMed ID: 27286324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus risk factors in renal transplantation with modern immunosuppression.
    Bataille S; Moal V; Gaudart J; Indreies M; Purgus R; Dussol B; Zandotti C; Berland Y; Vacher-Coponat H
    Transpl Infect Dis; 2010 Dec; 12(6):480-8. PubMed ID: 20629971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis.
    Kuo HT; Ye X; Sampaio MS; Reddy P; Bunnapradist S
    Transplantation; 2010 Nov; 90(10):1091-8. PubMed ID: 20885340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of mTOR inhibitors on the incidence of CMV infection in high-risk donor positive-recipient negative (D+/R-) kidney transplant recipients.
    Cristelli MP; Esmeraldo RM; Pinto CM; Sandes-Freitas TV; Felipe C; Lobo CF; Viana L; Mansur J; Stopa S; Santos DWC; Grenzi PC; Aguiar WF; Tedesco-Silva H; Pestana JOM
    Transpl Infect Dis; 2018 Aug; 20(4):e12907. PubMed ID: 29679515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.
    Forconi C; Gatault P; Miquelestorena-Standley E; Noble J; Al-Hajj S; Guillemain R; Stern M; Hoffmann T; Prat L; Suberbielle C; Masson E; Cesbron-Gautier A; Gaudy-Graffin C; Goudeau A; Thibault G; Ivanes F; Guibon R; Kazma I; Lebranchu Y; Büchler M; Magnan A; Halimi JM; Baron C
    J Heart Lung Transplant; 2017 Mar; 36(3):315-324. PubMed ID: 27751774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): experience from the RESITRA-REIPI cohort.
    Meije Y; Fortún J; Len Ó; Aguado JM; Moreno A; Cisneros JM; Gurguí M; Carratalà J; Muñoz P; Montejo M; Blanes M; Bou G; Pérez JL; Torre-Cisneros J; Ramos A; Pahissa A; Gavaldà J;
    Transpl Infect Dis; 2014 Jun; 16(3):387-96. PubMed ID: 24807640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
    Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of cytomegalovirus infection after deceased-donor kidney transplantation from hepatitis-C antibody positive donors to hepatitis-C antibody negative recipients.
    Yazawa M; Fülöp T; Cseprekal O; Talwar M; Balaraman V; Bhalla A; Azhar A; Kovesdy CP; Eason JD; Molnar MZ
    Ren Fail; 2020 Nov; 42(1):1083-1092. PubMed ID: 33100098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the development of cytomegalovirus infection following solid organ transplantation.
    da Cunha-Bang C; Sørensen SS; Iversen M; Sengeløv H; Hillingsø JG; Rasmussen A; Mortensen SA; Fox ZV; Kirkby NS; Christiansen CB; Lundgren JD
    Scand J Infect Dis; 2011 May; 43(5):360-5. PubMed ID: 21306196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMV mismatch does not affect patient and graft survival in UK renal transplant recipients.
    Johnson RJ; Clatworthy MR; Birch R; Hammad A; Bradley JA
    Transplantation; 2009 Jul; 88(1):77-82. PubMed ID: 19584684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.